259 related articles for article (PubMed ID: 33063132)
21. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
[TBL] [Abstract][Full Text] [Related]
22. Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer.
Liermann J; Syed M; Ben-Josef E; Schubert K; Schlampp I; Sprengel SD; Ristau J; Weykamp F; Röhrich M; Koerber SA; Haberkorn U; Debus J; Herfarth K; Giesel FL; Naumann P
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672893
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of target volumes defined by deformable and rigid registration of diagnostic PET/CT to planning CT in primary esophageal cancer.
Guo Y; Li J; Zhang P; Shao Q; Xu M; Li Y
Medicine (Baltimore); 2017 Jan; 96(1):e5528. PubMed ID: 28072693
[TBL] [Abstract][Full Text] [Related]
24. Staging and Response Evaluation to Neo-Adjuvant Chemoradiation in Esophageal Cancers Using 18FDG PET/ CT with Standardized Protocol.
Fatima N; Zaman MU; Zaman A; Zaman U; Tahseen R; Zaman S
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2003-2008. PubMed ID: 31350957
[TBL] [Abstract][Full Text] [Related]
25. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer.
Muijs CT; Beukema JC; Pruim J; Mul VE; Groen H; Plukker JT; Langendijk JA
Radiother Oncol; 2010 Nov; 97(2):165-71. PubMed ID: 20541273
[TBL] [Abstract][Full Text] [Related]
26. [Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma].
Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petenief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Hourry S; Talbot JN
Cancer Radiother; 2005 May; 9(3):152-60. PubMed ID: 16023043
[TBL] [Abstract][Full Text] [Related]
27. FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses.
Nkhali L; Thureau S; Edet-Sanson A; Doyeux K; Benyoucef A; Gardin I; Michel P; Vera P; Dubray B
Acta Oncol; 2015 Jun; 54(6):909-15. PubMed ID: 25417733
[TBL] [Abstract][Full Text] [Related]
28. Comparison of PET imaging of activated fibroblasts and
Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
[TBL] [Abstract][Full Text] [Related]
29. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma.
Konski A; Doss M; Milestone B; Haluszka O; Hanlon A; Freedman G; Adler L
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1123-8. PubMed ID: 15752892
[TBL] [Abstract][Full Text] [Related]
30. Biodistribution, pharmacokinetics, dosimetry of [
Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
[TBL] [Abstract][Full Text] [Related]
31. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
[TBL] [Abstract][Full Text] [Related]
32. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
33. Geometrical differences in target volumes based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography and four-dimensional computed tomography maximum intensity projection images of primary thoracic esophageal cancer.
Guo Y; Li J; Wang W; Zhang Y; Wang J; Duan Y; Shang D; Fu Z
Dis Esophagus; 2014; 27(8):744-50. PubMed ID: 24915760
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of [
Chen H; Zhao L; Ruan D; Pang Y; Hao B; Dai Y; Wu X; Guo W; Fan C; Wu J; Huang W; Lin Q; Sun L; Wu H
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):73-86. PubMed ID: 32588089
[TBL] [Abstract][Full Text] [Related]
35. Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma.
Hsu WH; Hsu PK; Wang SJ; Lin KH; Huang CS; Hsieh CC; Wu YC
Ann Thorac Surg; 2009 May; 87(5):1564-8. PubMed ID: 19379906
[TBL] [Abstract][Full Text] [Related]
36. Comparison of standardized uptake value-based positron emission tomography and computed tomography target volumes in esophageal cancer patients undergoing radiotherapy.
Vali FS; Nagda S; Hall W; Sinacore J; Gao M; Lee SH; Hong R; Shoup M; Emami B
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1057-63. PubMed ID: 20199850
[TBL] [Abstract][Full Text] [Related]
37. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
Vrieze O; Haustermans K; De Wever W; Lerut T; Van Cutsem E; Ectors N; Hiele M; Flamen P
Radiother Oncol; 2004 Dec; 73(3):269-75. PubMed ID: 15588870
[TBL] [Abstract][Full Text] [Related]
38.
Mantziari S; Pomoni A; Prior JO; Winiker M; Allemann P; Demartines N; Schäfer M
BMC Med Imaging; 2020 Jan; 20(1):7. PubMed ID: 31969127
[TBL] [Abstract][Full Text] [Related]
39. Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer.
Muijs CT; Beukema JC; Woutersen D; Mul VE; Berveling MJ; Pruim J; van der Jagt EJ; Hospers GA; Groen H; Plukker JT; Langendijk JA
Radiother Oncol; 2014 Nov; 113(2):188-92. PubMed ID: 25467002
[TBL] [Abstract][Full Text] [Related]
40. Dual-time point
Park S; Paeng JC; Kang CH; Cheon GJ; Kang KW; Chung JK; Lee DS
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1317-1328. PubMed ID: 29502309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
